101 related articles for article (PubMed ID: 25669088)
21. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
[TBL] [Abstract][Full Text] [Related]
22. The influence of technical complications on postoperative outcome and survival after esophagectomy.
Ferri LE; Law S; Wong KH; Kwok KF; Wong J
Ann Surg Oncol; 2006 Apr; 13(4):557-64. PubMed ID: 16485146
[TBL] [Abstract][Full Text] [Related]
23. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.
Schwameis K; Ba-Ssalamah A; Wrba F; Birner P; Prager G; Hejna M; Schmid R; Asari R; Zacherl J; Schoppmann SF
Anticancer Res; 2013 May; 33(5):2085-91. PubMed ID: 23645759
[TBL] [Abstract][Full Text] [Related]
24. Postoperative surveillance and prognostic factors in patients with esophageal cancer.
Kunisaki C; Makino H; Kimura J; Ota M; Takagawa R; Kosaka T; Ono HA; Akiyama H; Endo I
Hepatogastroenterology; 2014; 61(133):1262-73. PubMed ID: 25436294
[TBL] [Abstract][Full Text] [Related]
25. Cause of death during long-term follow-up for superficial esophageal adenocarcinoma.
Kauppi J; Gockel I; Rantanen T; Hansen T; Ristimäki A; Lang H; Sihvo E; Räsänen J; Junginger T; Salo JA
Ann Surg Oncol; 2013 Jul; 20(7):2428-33. PubMed ID: 23354564
[TBL] [Abstract][Full Text] [Related]
26. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
27. Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome?
Chiu CH; Chao YK; Chang HK; Tseng CK; Chan SC; Liu YH; Chen WH
Ann Surg Oncol; 2013 Dec; 20(13):4245-51. PubMed ID: 23959050
[TBL] [Abstract][Full Text] [Related]
28. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
29. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
Rades D; Schulte R; Yekebas EF; Homann N; Schild SE; Dunst J
Strahlenther Onkol; 2007 Jan; 183(1):10-6. PubMed ID: 17225940
[TBL] [Abstract][Full Text] [Related]
30. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
31. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
32. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
33. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors.
Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H
Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216
[TBL] [Abstract][Full Text] [Related]
34. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma.
Lee PC; Mirza FM; Port JL; Stiles BM; Paul S; Christos P; Altorki NK
J Thorac Cardiovasc Surg; 2011 May; 141(5):1196-206. PubMed ID: 21397267
[TBL] [Abstract][Full Text] [Related]
35. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
36. Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.
Melis M; McLoughlin JM; Dean EM; Siegel EM; Weber JM; Shah N; Kelley ST; Karl RC
J Surg Res; 2009 May; 153(1):114-20. PubMed ID: 19201421
[TBL] [Abstract][Full Text] [Related]
37. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution.
Ruol A; Castoro C; Portale G; Cavallin F; Sileni VC; Cagol M; Alfieri R; Corti L; Boso C; Zaninotto G; Peracchia A; Ancona E
Arch Surg; 2009 Mar; 144(3):247-54; discussion 254. PubMed ID: 19289664
[TBL] [Abstract][Full Text] [Related]
38. [Survival of patients with esophageal cancer subjected to total thoracic esophagectomy].
Braghetto I; Csendes A; Cornejo A; Amat J; Cardemil G; Burdiles P; Korn O
Rev Med Chil; 2000 Jan; 128(1):64-74. PubMed ID: 10883524
[TBL] [Abstract][Full Text] [Related]
39. Outcomes assessment of the surgical management of esophageal cancer in younger and older patients.
Markar SR; Karthikesalingam A; Low DE
Ann Thorac Surg; 2012 Nov; 94(5):1652-8. PubMed ID: 23098941
[TBL] [Abstract][Full Text] [Related]
40. The prognostic factors after radical esophagectomy for esophageal cancer with positive preoperative CEA.
Takemura M; Osugi H; Takada N; Okuda E; Ueno M; Kinoshita H
Hepatogastroenterology; 2004; 51(55):159-62. PubMed ID: 15011854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
